Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    MA04 - Health Policy and the Real World

    • 16:45 - 17:45
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Health Services Research/Health Economics
    • +

      MA04.01 - A Comparative Analysis of Lung Cancer Policies Across the Asia-Pacific Region

      16:45 - 16:50  |  Presenter: Rohini Omkar Prasad

      • Abstract

      Loading...

    • +

      MA04.02 - Lung Cancer Screening Utilization and Its Correlates in Sexual Minorities: An Analysis of the BRFSS 2018

      16:50 - 16:55  |  Presenter: Hui Xie

      • Abstract

      Loading...

    • +

      MA04.03 - Impact of Frailty Screening and Geriatrician-Led Comprehensive Geriatric Assessment in Frail Older Adults With Lung Cancer

      16:55 - 17:00  |  Presenter: Isabelle Lucy Rosemary Milner

      • Abstract

      Loading...

    • +

      MA04.04 - Assessing the Methodological Quality of Quality-of-Life Analyses in First-Line Lung Cancer Trials: A Systematic Review

      17:00 - 17:05  |  Presenter: Federico Daniel Waisberg

      • Abstract

      Loading...

    • +

      MA04.05 - Discussant

      17:05 - 17:15  |  Presenter: Pamela Samson

      • Abstract

      No abstract available for this presentation

    • +

      MA04.06 - Clinical Characteristics and Outcomes in Advanced KRAS Mutant NSCLC – A Multi-Centre Collaboration in Asia (ATORG-005)

      17:15 - 17:20  |  Presenter: Jiyun Lee

      • Abstract

      Loading...

    • +

      MA04.07 - Comparative Clinical Outcomes for Patients with NSCLC Harboring EGFR Exon 20 Insertion Mutations and Common EGFR Mutations

      17:20 - 17:25  |  Presenter: Nicolas Girard

      • Abstract

      Loading...

    • +

      MA04.08 - The Effect of Packed Red Blood Cell Transfusions on the Clinical Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients

      17:25 - 17:30  |  Presenter: Christopher Andrew D'Avella

      • Abstract

      Loading...

    • +

      MA04.09 - Impacts of Multidisciplinary Meeting Presentation: Drivers and Outcomes from a Population Registry Retrospective Cohort Study

      17:30 - 17:35  |  Presenter: Tiffany Lin

      • Abstract

      Loading...

    • +

      MA04.10 - Discussant

      17:35 - 17:45  |  Presenter: Mark Doherty

      • Abstract

      No abstract available for this presentation

  • +

    OA06 - Updates on EGFR Targeted Perioperative Therapy and Precision Adjuvant Chemotherapy

    • 16:45 - 17:45
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Early Stage/Localized Disease
    • +

      OA06.01 - Chair

      16:45 - 16:45  |  Presenter: Sun Min Lim

      • Abstract

      No abstract available for this presentation

    • +

      OA06.02 - Chair

      16:45 - 16:45  |  Presenter: Boris Sepesi

      • Abstract

      No abstract available for this presentation

    • +

      OA06.03 - Patient-Reported Outcomes from ADAURA: Osimertinib as Adjuvant Therapy in Patients with Resected EGFR Mutated (EGFRm) NSCLC

      16:45 - 16:55  |  Presenter: Margarita Majem

      • Abstract

      Loading...

    • +

      OA06.04 - Postoperative Chemotherapy Use and Outcomes from ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR Mutated NSCLC

      16:55 - 17:05  |  Presenter: Yi-long Wu

      • Abstract

      Loading...

    • +

      OA06.05 - Molecular and Clinical Features Associated with Relapse in Early Stage EGFR-Mutated NSCLC: A Single Institution Knowledge Bank

      17:05 - 17:15  |  Presenter: Stephanie Pei Li Saw

      • Abstract

      Loading...

    • +

      OA06.06 - Clinical/Biomarker Data for Neoadjuvant Atezolizumab in Resectable Stage IB-IIIB NSCLC: Primary Analysis in the LCMC3 Study

      17:15 - 17:25  |  Presenter: David Paul Carbone

      • Abstract

      Loading...

    • +

      OA06.07 - Discussant

      17:25 - 17:35  |  Presenter: Haiquan Chen

      • Abstract

      No abstract available for this presentation

    • +

      OA06.08 - Live Q&A

      17:35 - 17:45

      • Abstract

      No abstract available for this presentation

  • +

    PL03 - Bench to Bedside (Immunology) (Japanese, Mandarin, Spanish Translation Available)

    • 18:00 - 20:00
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL03.01 - Chair

      18:00 - 18:00  |  Presenter: Silvia Novello

      • Abstract

      No abstract available for this presentation

    • +

      PL03.02 - Chair

      18:00 - 18:00  |  Presenter: Benjamin Besse

      • Abstract

      No abstract available for this presentation

    • +

      PL03.03 - NSCLC and Immune Evasion: Insights from TRACERx

      18:00 - 18:20  |  Presenter: Charles Swanton

      • Abstract

      No abstract available for this presentation

    • +

      PL03.04 - Considering Biology of "Nodes" in Response to PD-1 Blockade in NSCLC

      18:20 - 18:40  |  Presenter: Matthew D Hellmann

      • Abstract

      No abstract available for this presentation

    • +

      PL03.05 - Cell Therapy for Solid Tumors

      18:40 - 19:00  |  Presenter: Prasad S Adusumilli

      • Abstract

      Loading...

    • +

      PL03.06 - Improving Outcomes with Immunotherapy: Lessons from Other Diseases

      19:00 - 19:20  |  Presenter: Carolyn Roberts

      • Abstract

      Loading...

    • +

      PL03.07 - Monitoring Disease Through Genomic/Immune Markers

      19:20 - 19:40  |  Presenter: Qing Zhou

      • Abstract

      No abstract available for this presentation

    • +

      PL03.08 - Live Q&A

      19:40 - 20:00

      • Abstract

      No abstract available for this presentation